Results 71 to 80 of about 328,885 (284)

Clumping factor A, von Willebrand factor‐binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall

open access: yesJournal of Thrombosis and Haemostasis, 2017
Essentials Staphylococcus aureus (S. aureus) binds to endothelium via von Willebrand factor (VWF). Secreted VWF‐binding protein (vWbp) mediates S. aureus adhesion to VWF under shear stress.
J. Claes   +11 more
semanticscholar   +1 more source

Value of Von Willebrand Factor as a Predictor for Osteoporosis Development in Women with Hypothyroidism

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2015
The paper presents the study of the value of von Willebrand factor as a marker of endothelial dysfunction for osteoporosis development and for prediction of risk of its formation in women with hypothyroidism. Postmenopausal women with hypothyroidism have
I.V. Pankiv
doaj   +1 more source

Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms

open access: yesJournal of Thrombosis and Haemostasis, 2016
Essentials von Willebrand factor (VWF) and factor VIII (FVIII) levels are modulated by age and ABO status. The effect of aging and ABO blood type on VWF and FVIII was assessed in 207 normal individuals.
S. Albánez   +6 more
semanticscholar   +1 more source

Von Willebrand factor revisited

open access: yesJournal of Interventional Cardiology, 2017
Degenerative aortic valve stenosis is the most common valvular heart disease seen in developed countries. Since the implementation of transcatheter aortic valve replacement, there has been a surge of efforts to improve procedural technique as well as reduce mortality.
Senan J. Yasar   +3 more
openaire   +3 more sources

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease

open access: yesTH Open, 2021
Background The efficacy and safety of wilate (human von Willebrand factor/coagulation factor VIII) in patients with von Willebrand disease (VWD) has been demonstrated in clinical trials.
Michelle Sholzberg   +11 more
doaj   +1 more source

ADAMTS‐13 and von Willebrand factor: a dynamic duo

open access: yesJournal of Thrombosis and Haemostasis, 2017
von Willebrand factor (VWF) is a key player in hemostasis, acting as a carrier for factor VIII and capturing platelets at sites of vascular damage.
K. South, D. Lane
semanticscholar   +1 more source

The epitope of the antibody used in the REAADS VWF activity assay is quaternary

open access: yesThrombosis Journal
The REAADS VWF activity assay is often assumed to be specific for the A1 domain, the portion of VWF that binds platelet GPIbα. We tested this assay on the A1A2A3 region of VWF with each domain expressed independently of one another and together in ...
Alexander Tischer   +2 more
doaj   +1 more source

DISCOVERY OF TYPE 3 VON WILLEBRAND DISEASE IN A COHORT OF PATIENTS WITH SUSPECTED HEMOPHILIA A IN CÔTE D’IVOIRE

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2020
Aim : Type 3 von Willebrand disease (VWD) is the most severe form of VWD, characterized by a near-total absence of von Willebrand factor (vWF) leading to a huge deficiency in plasmatic factor VIII (FVIII). VWD may be confused with hemophilia A, sometimes
Adia Eusèbe Adjambri   +7 more
doaj   +1 more source

Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo.

open access: yesBlood, 2016
UNLABELLED Circulating factor VIII (FVIII) is derived from liver and from extrahepatic sources probably of endothelial origin, but the vascular sites of FVIII production remain unclear.
Junliang Pan   +12 more
semanticscholar   +1 more source

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease. [PDF]

open access: yesPLoS ONE, 2016
Von Willebrand disease (VWD) may be caused by an impaired von Willebrand factor (VWF) synthesis, its increased clearance or abnormal function, or combinations of these factors.
Alessandra Casonato   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy